MAL2 and Alzheimer disease: AD samples in GSE118553 were divided into a “high-expression group” and a “low-expression group.” We acquired 17, 9, 1, 7, and 33 significant gene sets enriched in the expression groups of AP3B2, GABRD, GPR158, KIAA0513, and MAL2, respectively (Supplementary Table 4).